Atlas Trials

V600-mutated BRAF Metastatic Melanoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch V600-mutated BRAF Metastatic Melanoma

RecordFirmDate
A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma (NCT01826448)Daiichi Sankyo2013-11-05

Track V600-mutated BRAF Metastatic Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.